z-logo
open-access-imgOpen Access
Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024)
Author(s) -
Fengjiang Qu,
Di Wu,
Yunjiang Liu,
Wei Gao,
Shu Wang,
Siyuan Wang,
Feng Jin,
Bin Chen,
Jian Huang,
Shanshan Sun,
Zhun Fan
Publication year - 2022
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000002309
Subject(s) - medicine , breast cancer , clinical trial , sentinel node , sentinel lymph node , multicenter trial , surgery , breast surgery , biopsy , cancer , randomized controlled trial , multicenter study

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here